LYNPARZA is a type of targeted therapy called a PARP inhibitor. It is a prescription treatment taken by mouth for women with certain types of ovarian cancer.
LYNPARZA is different from chemotherapy because it takes advantage of DNA damage so that cancer cells can’t get the help they need to survive. LYNPARZA can also affect healthy cells as well.
In ovarian cancer, cells in the ovaries grow out of control.
This growth creates damage that must be repaired in order for the cancer cells to keep growing.
One way to fix this damage is to use PARP, which is an enzyme that has many jobs inside cells—including helping to repair damage.
If PARP is allowed to repair damage, cancer cells can survive, and tumors can continue to grow. That’s why it’s important to try and stop PARP.
That’s where LYNPARZA comes in. LYNPARZA works in 2 ways to help kill cancer cells:
By preventing damage repair and harming cancer cells, LYNPARZA can help stop the tumor from growing.
Now you know how LYNPARZA can help maintain your body’s response to chemotherapy after treatment ends—or fight back after cancer returns following 3 or more chemotherapy treatments. Take the quiz below to put your LYNPARZA knowledge to the test.
PARP=poly (ADP-ribose) polymerase.
Cancer cell DNA
LYNPARZA is a prescription medicine used for:
It is not known if LYNPARZA is safe and effective in children.
LYNPARZA may cause serious side effects, including:
Bone marrow problems called Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Some people who have ovarian cancer and who have received previous treatment with chemotherapy, radiotherapy, or certain other medicines for their cancer have developed MDS or AML during treatment with LYNPARZA. MDS or AML may lead to death. If you develop MDS or AML, your health care provider will stop treatment with LYNPARZA.
Symptoms of low blood cell counts are common during treatment with LYNPARZA, but can be a sign of serious bone marrow problems, including MDS or AML. Symptoms may include: weakness, weight loss, fever, frequent infections, blood in urine or stool, shortness of breath, feeling very tired, bruising or bleeding more easily.
Your health care provider will do blood tests to check your blood cell counts:
Lung problems (pneumonitis). Tell your health care provider if you have any new or worsening symptoms of lung problems, including shortness of breath, fever, cough, or wheezing. Your health care provider may do a chest x-ray if you have any of these symptoms. Your health care provider may temporarily stop treatment or completely stop treatment if you develop pneumonitis. Pneumonitis may lead to death.
Before you take LYNPARZA, tell your health care provider about all your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking LYNPARZA and certain other medicines may affect how LYNPARZA works and may cause side effects.
How should I take LYNPARZA?
What should I avoid while taking LYNPARZA?
LYNPARZA may cause serious side effects. The most common side effects of LYNPARZA are:
These are not all the possible side effects of LYNPARZA. Call your health care provider for medical advice about side effects.